Cure rate, duration required for complete cure and recurrence rate of onychomycosis according to clinical factors in Korean patients

Mycoses

Volumn 54, Issue 5, 2011, Pages

  Ko, Joo Yeon ^a   Lee, Ha Eun ^a   Jae, Hur ^a   Oh, Dae Heon ^a   Kim, Joung Soo ^a   Yu, Hee Joon ^a  

^a Hanyang University College of Medicine   (South Korea)

Author keywords

Cure rate; Duration required for complete cure; Onychomycosis; Recurrence rate

Indexed keywords

AMOROLFINE; ITRACONAZOLE; POTASSIUM HYDROXIDE; TERBINAFINE;

ADOLESCENT; ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CHILD; CONTROLLED STUDY; DIABETES MELLITUS; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; GROUPS BY AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; NEWBORN; ONYCHOMYCOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; SEX DIFFERENCE; SOUTH KOREA; TOPICAL TREATMENT; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KOREA; MALE; MIDDLE AGED; ONYCHOMYCOSIS; RECURRENCE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80052809143     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2010.01928.x     Document Type: Article

References (19)

1. Szepietowski JC, Reich A, Garlowska E et al. Factors influencing coexistence of toenail onychomycosis with tinea pedis and other dermatomycoses: a survey of 2761 patients. Arch Dermatol 2006; 142: 1279-84.
2. Elewski BE, Hay RJ. Novel treatment strategies for superficial mycoses: introduction. J Am Acad Dermatol 1999; 40(Suppl.): 1-2.
3. Zaias N. Onychomycosis. Arch Dermatol 1972; 105: 263-74.
4. Roberts DT. Oral therapeutic agents in fungal nail disease. J Am Acad Dermatol 1994; 31(Suppl.): 78-81.
5. Elewski BE. A full cure for onychomycosis is not always possible. Arch Dermatol 1999; 133: 852-3.
6. Scher RK, Tavakkol A, Sigurgeirsson B et al. Onychomycosis: diagnosis and definition of cure. J Am Acad Dermatol 2007; 56: 939-44.
7. Kim JE, Park HJ, Lee JY et al. The compliance and long term follow up of onychomycosis treatment. Korean J Med Mycol 2003; 8: 110-7.
8. Kim DH, Park HJ, Lee JY et al. Clinical study of onychomycosis: factors contributing to the prognosis and response rate according to each factor and summation of factors. Korean J Med Mycol 2005; 10: 55-69.
9. Yu HJ, Kwon HM, Oh DH, Kim JS. Is slow nail growth a risk factor for onychomycosis? Clin Exp Dermatol 2004; 29: 415-8.
10. Scher RK, Baran R. Onychomycosis in clinical practice: factors contributing to recurrence. Br J Dermatol 2003; 149(Suppl. 65): 5-9.
11. Pierard G. Onychomycosis and other superficial fungal infections of the foot in the elderly: a pan-European survey. Dermatology 2001; 202: 220-4.
12. Orentreich N, Markofsky J, Vogelman JH. The effect of aging on the rate of linear nail growth. J Invest Dermatol 1979; 73: 126-30.
13. Park JM, Kwon SJ, Yu HJ. Comparison the growth rate between the affected and the unaffected great toenail in the same patients with onychomycosis. Korean J Med Mycol 2000; 5: 173-8.
14. Farkas B, Paul C, Dobozy A et al. Terbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trial. Br J Dermatol 2002; 146: 254-60.
15. Robbins JM. Treatment of onychomycosis in the diabetic patient population. J Diabetes Complications 2003; 17: 98-104.
16. Gupta AK, Lynde CW, Konnikov N. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. J Am Acad Dermatol 2001; 44: 485-91.
17. Cohen AD, Medvesovsky E, Shalev R et al. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis. J Dermatolog Treat 2003; 14: 237-42.
18. Gentles JC. Laboratory investigations of dermatophyte infections of nails. Sabouraudia 1971; 9: 149-52.
19. ® stain. Korean J Med Mycol 1998; 3: 125-31.